BriaCell Therapeutics Corp. (TSX:BCT)
Canada
· Delayed Price · Currency is CAD 5.52
+0.04 (0.73%)
Apr 28, 2026, 3:53 PM EST
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of CAD 40.02 million as of April 29, 2026. Its market cap has increased by 84.75% in one year.
Market Cap
40.02M
Enterprise Value
-1.49M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.52
Market Cap Chart
Since December 3, 2014, BriaCell Therapeutics's market cap has increased from 24.42M to 40.02M, an increase of 63.91%. That is a compound annual growth rate of 4.43%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telescope Innovations | 37.98M |
| Lobe Sciences | 36.93M |
| MedMira | 42.10M |
| Defence Therapeutics | 42.33M |
| Microbix Biosystems | 33.82M |
| Devonian Health Group | 33.09M |
| Resverlogix | 31.62M |
| Quantum BioPharma | 28.85M |